|
Delayed
OTC Markets
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | -99.33% |
| 08-06 | Morphic Medical Announces Board Appointments, Effective August 6, 2026 | CI |
| 08-03 | Morphic Medical Inc. Provides Update On Reset System Clinical And Commercial Progress | CI |
| Market Cap | 440K 395K 365K 331K 618K 41.95M 626K 4.37M 1.74M 21.95M 1.65M 1.62M 69.69M | P/E 2019 |
-1.12x | P/E 2020 | -0.03x |
|---|---|---|---|---|---|
| Enterprise Value | 3.28M 2.94M 2.72M 2.46M 4.6M 312M 4.66M 32.53M 12.95M 163M 12.31M 12.05M 519M | EV / Sales 2019 |
-
| EV / Sales 2020 | - |
| Free-Float |
-
| Yield 2019 * |
-
| Yield 2020 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mike Gutteridge
CEO | Chief Executive Officer | - | 05/08/2025 |
Jane Wright
DFI | Director of Finance/CFO | 57 | 01/08/2025 |
| Chief Tech/Sci/R&D Officer | - | 01/04/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Ginger Glaser
BRD | Director/Board Member | - | 20/10/2020 |
Alex Escalona
BRD | Director/Board Member | - | - |
John R. Barr
BRD | Director/Board Member | 69 | 01/10/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 28/1/21 | Free | Chairman | 1,384,483 | 0.4875% | ||
| 28/1/21 | Free | Chief Executive Officer | 11,075,869 | 3.8998% |
| 2019 | 2020 | |
|---|---|---|
| Net sales | - | - |
| Net income | -17.33M -15.55M -14.38M -13.02M -24.33M -1.65B -24.62M -172M -68.47M -864M -65.04M -63.67M -2.74B | -11.14M -9.99M -9.24M -8.37M -15.63M -1.06B -15.82M -110M -43.99M -555M -41.79M -40.91M -1.76B |
| Net Debt | 2.89M 2.59M 2.39M 2.17M 4.05M 275M 4.1M 28.63M 11.4M 144M 10.83M 10.61M 457M | 2.84M 2.55M 2.35M 2.13M 3.98M 270M 4.03M 28.16M 11.21M 141M 10.65M 10.43M 449M |
Employees
-
Sector
-
- Stock Market
- Stocks
- GIDYL Stock
Select your edition
All financial news and data tailored to specific country editions
















